{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:56Z","timestamp":1790808236913,"version":"4.1.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/pas.0b013e3181f01916","type":"journal-article","created":{"date-parts":[[2010,9,24]],"date-time":"2010-09-24T13:18:32Z","timestamp":1285334312000},"page":"1472-1479","source":"Crossref","is-referenced-by-count":145,"title":["Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the Breast"],"prefix":"10.1097","volume":"34","author":[{"given":"Emad A.","family":"Rakha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Des G.","family":"Powe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Benhasouna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryou B.","family":"Lambros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge S.","family":"Reis-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ijc.21004","article-title":"High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses","volume":"116","author":"Abd El-Rehim","year":"2005","journal-title":"Int J Cancer"},{"key":"R2-10-20210131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R","article-title":"Cadherin-catenin complex: protein interactions and their implications for cadherin function","volume":"61","author":"Aberle","year":"1996","journal-title":"J Cell Biochem"},{"key":"R3-10-20210131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1309\/FDHX-L92R-BATQ-2GE0","article-title":"Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications","volume":"115","author":"Acs","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R4-10-20210131","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0959-8049(00)00062-9","article-title":"Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance","volume":"36","author":"Asgeirsson","year":"2000","journal-title":"Eur J Cancer"},{"key":"R5-10-20210131","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35000034","article-title":"The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells","volume":"2","author":"Batlle","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R6-10-20210131","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1002\/j.1460-2075.1995.tb00301.x","article-title":"E-cadherin is a tumour\/invasion suppressor gene mutated in human lobular breast cancers","volume":"14","author":"Berx","year":"1995","journal-title":"Embo J"},{"key":"R7-10-20210131","first-page":"1919","article-title":"E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"key":"R8-10-20210131","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D","article-title":"Mutations of the human E-cadherin (CDH1) gene","volume":"12","author":"Berx","year":"1998","journal-title":"Hum Mutat"},{"key":"R9-10-20210131","first-page":"11","article-title":"Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness","volume":"1198","author":"Birchmeier","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"R10-10-20210131","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/hupa.2002.124789","article-title":"Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias","volume":"33","author":"Bratthauer","year":"2002","journal-title":"Hum Pathol"},{"key":"R11-10-20210131","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s004280050105","article-title":"Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas","volume":"431","author":"Bukholm","year":"1997","journal-title":"Virchows Arch"},{"key":"R12-10-20210131","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00125480-200105000-00005","article-title":"Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast","volume":"8","author":"Chan","year":"2001","journal-title":"Adv Anat Pathol"},{"key":"R13-10-20210131","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ijc.2910600308","article-title":"Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas","volume":"60","author":"Cowley","year":"1995","journal-title":"Int J Cancer"},{"key":"R14-10-20210131","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0b013e318158d6c5","article-title":"Aberrant expression of E-cadherin in lobular carcinomas of the breast","volume":"32","author":"Da Silva","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R15-10-20210131","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9","article-title":"Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ","volume":"183","author":"De Leeuw","year":"1997","journal-title":"J Pathol"},{"key":"R16-10-20210131","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ccr.2006.09.013","article-title":"Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis","volume":"10","author":"Derksen","year":"2006","journal-title":"Cancer Cell"},{"key":"R17-10-20210131","first-page":"75","article-title":"The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin","volume":"152","author":"Dillon","year":"1998","journal-title":"Am J Pathol"},{"key":"R18-10-20210131","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int J Cancer"},{"key":"R19-10-20210131","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.1992.tb01032.x","article-title":"Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up","volume":"20","author":"Ellis","year":"1992","journal-title":"Histopathology"},{"key":"R20-10-20210131","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"R21-10-20210131","first-page":"239","article-title":"The Breast","author":"Elston","year":"1998"},{"key":"R22-10-20210131","first-page":"987","article-title":"Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma","volume":"142","author":"Gamallo","year":"1993","journal-title":"Am J Pathol"},{"key":"R23-10-20210131","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1309\/JMRD-W08Y-6K8M-7AD8","article-title":"Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?","volume":"118","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R24-10-20210131","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1309\/B0DD-4M7H-GJG1-7KCW","article-title":"E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions","volume":"115","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"R25-10-20210131","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/1097-0142(20010815)92:4<738::AID-CNCR1377>3.0.CO;2-Z","article-title":"Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast","volume":"92","author":"Goldstein","year":"2001","journal-title":"Cancer"},{"key":"R26-10-20210131","first-page":"5195","article-title":"E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas","volume":"55","author":"Graff","year":"1995","journal-title":"Cancer Res"},{"key":"R27-10-20210131","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1038\/sj.onc.1202790","article-title":"Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility","volume":"18","author":"Handschuh","year":"1999","journal-title":"Oncogene"},{"key":"R28-10-20210131","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0955-0674(96)80110-4","article-title":"Cadherins and catenins in development","volume":"8","author":"Huber","year":"1996","journal-title":"Curr Opin Cell Biol"},{"key":"R29-10-20210131","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1242\/jcs.110.15.1759","article-title":"A specific domain in alpha-catenin mediates binding to beta-catenin or plakoglobin","volume":"110","author":"Huber","year":"1997","journal-title":"J Cell Sci"},{"key":"R30-10-20210131","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/sj.bjc.6690815","article-title":"Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer","volume":"81","author":"Huiping","year":"1999","journal-title":"Br J Cancer"},{"key":"R31-10-20210131","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00000478-200102000-00011","article-title":"Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization","volume":"25","author":"Jacobs","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R32-10-20210131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<45::AID-IJC9>3.0.CO;2-G","article-title":"Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers","volume":"83","author":"Jacquemier","year":"1999","journal-title":"Int J Cancer"},{"key":"R33-10-20210131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)65129-2","article-title":"Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation","volume":"155","author":"Keller","year":"1999","journal-title":"Am J Pathol"},{"key":"R34-10-20210131","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0168-9525(93)90250-L","article-title":"From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion","volume":"9","author":"Kemler","year":"1993","journal-title":"Trends Genet"},{"key":"R35-10-20210131","first-page":"7167","article-title":"Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis","volume":"63","author":"Korkola","year":"2003","journal-title":"Cancer Res"},{"key":"R36-10-20210131","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.10176","article-title":"CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk","volume":"98","author":"Lei","year":"2002","journal-title":"Int J Cancer"},{"key":"R37-10-20210131","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/jcp.2007.053991","article-title":"Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype","volume":"61","author":"Mahler-Araujo","year":"2008","journal-title":"J Clin Pathol"},{"key":"R38-10-20210131","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/modpathol.3800362","article-title":"E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast","volume":"18","author":"Mastracci","year":"2005","journal-title":"Mod Pathol"},{"key":"R39-10-20210131","first-page":"1731","article-title":"Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas","volume":"143","author":"Moll","year":"1993","journal-title":"Am J Pathol"},{"key":"R40-10-20210131","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2559.2002.01392.x","article-title":"Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival","volume":"40","author":"Nakopoulou","year":"2002","journal-title":"Histopathology"},{"key":"R41-10-20210131","first-page":"1696","article-title":"Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis","volume":"53","author":"Oka","year":"1993","journal-title":"Cancer Res"},{"key":"R42-10-20210131","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jcp.2007.052704","article-title":"Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival","volume":"61","author":"Paredes","year":"2008","journal-title":"J Clin Pathol"},{"key":"R43-10-20210131","first-page":"1319","article-title":"Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines","volume":"11","author":"Pierceall","year":"1995","journal-title":"Oncogene"},{"key":"R44-10-20210131","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2005.02156.x","article-title":"E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance","volume":"46","author":"Rakha","year":"2005","journal-title":"Histopathology"},{"key":"R45-10-20210131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/path.1916","article-title":"Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation","volume":"208","author":"Rakha","year":"2006","journal-title":"J Pathol"},{"key":"R46-10-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-007-9768-4","article-title":"Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast","volume":"111","author":"Rakha","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R48-10-20210131","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/mp.54.2.91","article-title":"Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas","volume":"54","author":"Rieger-Christ","year":"2001","journal-title":"Mol Pathol"},{"key":"R49-10-20210131","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/sj.onc.1207439","article-title":"Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions","volume":"23","author":"Sarrio","year":"2004","journal-title":"Oncogene"},{"key":"R50-10-20210131","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0002-9440(10)63783-2","article-title":"Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer","volume":"164","author":"Shibata","year":"2004","journal-title":"Am J Pathol"},{"key":"R51-10-20210131","first-page":"365","article-title":"Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities","volume":"2","author":"Sommers","year":"1991","journal-title":"Cell Growth Differ"},{"key":"R52-10-20210131","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1044-579X(02)00057-3","article-title":"Epigenetic versus genetic alterations in the inactivation of E-cadherin","volume":"12","author":"Strathdee","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"R53-10-20210131","first-page":"23","article-title":"World Health Organization Classification of Tumours","author":"Tavassoli","year":"2003"},{"key":"R54-10-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0092-8674(91)90143-M","article-title":"Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role","volume":"66","author":"Vleminckx","year":"1991","journal-title":"Cell"},{"key":"R55-10-20210131","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","article-title":"E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis","volume":"76","author":"Vos","year":"1997","journal-title":"Br J Cancer"},{"key":"R56-10-20210131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/adpa.2002.36660","article-title":"E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma","volume":"6","author":"Wahed","year":"2002","journal-title":"Ann Diagn Pathol"},{"key":"R57-10-20210131","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrclinonc.2009.166","article-title":"Histological and molecular types of breast cancer: is there a unifying taxonomy?","volume":"6","author":"Weigelt","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"R58-10-20210131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/path.2629","article-title":"The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type","volume":"220","author":"Weigelt","year":"2010","journal-title":"J Pathol"},{"key":"R59-10-20210131","doi-asserted-by":"crossref","first-page":"7416","DOI":"10.1073\/pnas.92.16.7416","article-title":"Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas","volume":"92","author":"Yoshiura","year":"1995","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0b013e3181f01916","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:36:48Z","timestamp":1786041408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000478-201010000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e3181f01916","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}